Impax Asset Management Group plc Acquires 300 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Impax Asset Management Group plc boosted its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 17.5% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,014 shares of the specialty pharmaceutical company’s stock after acquiring an additional 300 shares during […]

Related Keywords

Canada ,United States ,Neenam Patil ,Ricke Winningham , ,Nasdaq ,News Ratings For Jazz Pharmaceuticals Daily ,Royal Bank ,Insider Activity At Jazz Pharmaceuticals ,Jazz Pharmaceuticals ,Exchange Commission ,Impax Asset Management Group ,Quarter For Jazz Pharmaceuticals ,Needham Company ,Vanguard Group Inc ,Us Bancorp ,Advisor Group ,Jazz Pharmaceuticals Trading ,Cantor Fitzgerald ,Securities Exchange Commission ,Aviva Plc ,Free Report ,Asset Management Group ,Asset Management Gmbh ,Vanguard Group ,Director Rick ,Get Free Report ,Visit Holdingschannel ,Jazz Pharmaceuticals Daily ,Nasdaq Jazz ,Jazz ,Medical ,G5087110 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,